ALC 0 3 0 3 B-clinical_variable
> 4 5 4 5 O
5000 6 10 6 10 B-lower_bound

ALC 0 3 11 14 B-clinical_variable
> 4 5 15 16 O
5000 6 10 17 21 B-lower_bound
on 11 13 22 24 O
2 14 15 25 26 O
consecutive 16 27 27 38 O
occasions 28 37 39 48 O
and 38 41 49 52 O
increasing 42 52 53 63 O

AST 0 3 64 67 B-clinical_variable
and 4 7 68 71 O
ALT 8 11 72 75 B-clinical_variable
< 12 13 76 77 O
2 14 15 78 79 B-upper_bound
times 16 21 80 85 I-upper_bound
the 22 25 86 89 I-upper_bound
upper 26 31 90 95 I-upper_bound
limit 32 37 96 101 I-upper_bound
of 38 40 102 104 I-upper_bound
normal 41 47 105 111 I-upper_bound

Age 0 3 112 115 B-age
> 4 5 116 117 O
or 6 8 118 120 O
equal 9 14 121 126 O
to 15 17 127 129 O
18 18 20 130 132 B-lower_bound
years 21 26 133 138 I-lower_bound
old 27 30 139 142 O
and 31 34 143 146 O
< 35 36 147 148 O
80 37 39 149 151 B-upper_bound
years 40 45 152 157 I-upper_bound
of 46 48 158 160 O
age 49 52 161 164 B-age
during 53 59 165 171 O
the 60 63 172 175 O
course 64 70 176 182 O
of 71 73 183 185 O
therapy 74 81 186 193 O

Conditions 0 10 194 204 O
which 11 16 205 210 O
would 17 22 211 216 O
increase 23 31 217 225 O
risk 32 36 226 230 O
of 37 39 231 233 O
lactic 40 46 234 240 B-chronic_disease
acidosis 47 55 241 249 I-chronic_disease

Current 0 7 250 257 O
or 8 10 258 260 O
planned 11 18 261 268 B-pregnancy
pregnancy 19 28 269 278 I-pregnancy

Currently 0 9 279 288 O
taking 10 16 289 295 O
metformin 17 26 296 305 B-treatment
, 26 27 305 306 O
sulfonylureas 28 41 307 320 B-treatment
, 41 42 320 321 O
thiazolidinediones 43 61 322 340 B-treatment
or 62 64 341 343 O
insulin 65 72 344 351 B-treatment
for 73 76 352 355 O
any 77 80 356 359 O
reason 81 87 360 366 O

ECOG 0 4 367 371 B-clinical_variable
performance 5 16 372 383 I-clinical_variable
0‐2 17 20 384 387 B-lower_bound

GFR 0 3 388 391 B-clinical_variable
> 4 5 392 393 O
59 6 8 394 396 B-lower_bound

Gilbert 0 7 397 404 B-chronic_disease
disease 8 15 405 412 I-chronic_disease

HgbA1C 0 6 413 419 B-clinical_variable
> 7 8 420 421 O
6.5 9 12 422 425 B-lower_bound

History 0 7 426 433 O
of 8 10 434 436 O
allergic 11 19 437 445 O
reactions 20 29 446 455 O
attributed 30 40 456 466 O
to 41 43 467 469 O
metformin 44 53 470 479 B-allergy_name
or 54 56 480 482 O
other 57 62 483 488 O
biguanides 63 73 489 499 B-allergy_name

History 0 7 500 507 O
of 8 10 508 510 O
congestive 11 21 511 521 B-chronic_disease
heart 22 27 522 527 I-chronic_disease
failure 28 35 528 535 I-chronic_disease
defined 36 43 536 543 O
as 44 46 544 546 O
NYHA 47 51 547 551 B-clinical_variable
class 52 57 552 557 I-clinical_variable
III 58 61 558 561 B-lower_bound
or 62 64 562 564 O
IV 65 67 565 567 B-upper_bound

History 0 7 568 575 O
of 8 10 576 578 O
metabolic 11 20 579 588 B-chronic_disease
acidosis 21 29 589 597 I-chronic_disease

Known 0 5 598 603 O
alcoholism 6 16 604 614 O
or 17 19 615 617 O
ingestion 20 29 618 627 O
of 30 32 628 630 O
more 33 37 631 635 O
than 38 42 636 640 O
3 43 44 641 642 B-lower_bound
alcoholic 45 54 643 652 O
beverages 55 64 653 662 O
per 65 68 663 666 O
day 69 72 667 670 O

Known 0 5 671 676 O
diabetes 6 14 677 685 B-chronic_disease
( 15 16 686 687 I-chronic_disease
type 16 20 687 691 I-chronic_disease
1 21 22 692 693 I-chronic_disease
or 23 25 694 696 I-chronic_disease
2 26 27 697 698 I-chronic_disease
) 27 28 698 699 I-chronic_disease

Less 0 4 700 704 O
than 5 9 705 709 O
55 10 12 710 712 B-upper_bound
% 12 13 712 713 I-upper_bound
atypical 14 22 714 722 B-clinical_variable
cells 23 28 723 728 I-clinical_variable

Life 0 4 729 733 B-clinical_variable
expectancy 5 15 734 744 I-clinical_variable
> 16 17 745 746 O
12 18 20 747 749 B-lower_bound
months 21 27 750 756 I-lower_bound

Ongoing 0 7 757 764 O
or 8 10 765 767 O
active 11 17 768 774 B-chronic_disease
infection 18 27 775 784 I-chronic_disease
concerning 28 38 785 795 O
for 39 42 796 799 O
sepsis 43 49 800 806 B-chronic_disease
or 50 52 807 809 O
SIRS 53 57 810 814 B-chronic_disease

Patient 0 7 815 822 O
must 8 12 823 827 O
be 13 15 828 830 O
able 16 20 831 835 O
to 21 23 836 838 O
drink 24 29 839 844 O
and 30 33 845 848 O
eat 34 37 849 852 O
more 38 42 853 857 O
than 43 47 858 862 O
75 48 50 863 865 B-lower_bound
% 50 51 865 866 I-lower_bound
of 52 54 867 869 O
their 55 60 870 875 O
usual 61 66 876 881 O
daily 67 72 882 887 O
meals 73 78 888 893 O

Patient 0 7 894 901 O
with 8 12 902 906 O
confirmed 13 22 907 916 O
del11q 23 29 917 923 B-chronic_disease
mutation 30 38 924 932 I-chronic_disease
may 39 42 933 936 O
be 43 45 937 939 O
included 46 54 940 948 O
if 55 57 949 951 O
untreated 58 67 952 961 O

Patients 0 8 962 970 O
less 9 13 971 975 O
than 14 18 976 980 O
30 19 21 981 983 B-upper_bound
days 22 26 984 988 I-upper_bound
from 27 31 989 993 O
last 32 36 994 998 O
treatment 37 46 999 1008 B-treatment
for 47 50 1009 1012 O
CLL 51 54 1013 1016 B-cancer

Patients 0 8 1017 1025 O
should 9 15 1026 1032 O
have 16 20 1033 1037 O
a 21 22 1038 1039 O
confirmed 23 32 1040 1049 O
diagnosis 33 42 1050 1059 O
of 43 45 1060 1062 O
chronic 46 53 1063 1070 B-cancer
lymphocytic 54 65 1071 1082 I-cancer
leukemia 66 74 1083 1091 I-cancer

Patients 0 8 1092 1100 O
who 9 12 1101 1104 O
relapse 13 20 1105 1112 O
after 21 26 1113 1118 O
receiving 27 36 1119 1128 O
a 37 38 1129 1130 O
one 39 42 1131 1134 B-lower_bound
or 43 45 1135 1137 O
more 46 50 1138 1142 O
courses 51 58 1143 1150 O
of 59 61 1151 1153 O
fludarabine 62 73 1154 1165 B-treatment
, 73 74 1165 1166 O
bendamustine 75 87 1167 1179 B-treatment
, 87 88 1179 1180 O
cytoxan 89 96 1181 1188 B-treatment
, 96 97 1188 1189 O
rituxan 98 105 1190 1197 B-treatment
, 105 106 1197 1198 O
chlorambucil 107 119 1199 1211 B-treatment
, 119 120 1211 1212 O
or 121 123 1213 1215 O
campath 124 131 1216 1223 B-treatment
based 132 137 1224 1229 I-treatment
therapy 138 145 1230 1237 I-treatment

Patients 0 8 1238 1246 O
with 9 13 1247 1251 O
active 14 20 1252 1258 O
CLL 21 24 1259 1262 B-cancer
disease 25 32 1263 1270 I-cancer
requiring 33 42 1271 1280 O
urgent 43 49 1281 1287 O
chemotherapy 50 62 1288 1300 B-treatment

Uncontrolled 0 12 1301 1313 B-chronic_disease
intercurrent 13 25 1314 1326 I-chronic_disease
illness 26 33 1327 1334 I-chronic_disease
including 34 43 1335 1344 O
, 43 44 1344 1345 O
but 45 48 1346 1349 O
not 49 52 1350 1353 O
limited 53 60 1354 1361 O
to 61 63 1362 1364 O
, 63 64 1364 1365 O
ongoing 65 72 1366 1373 O
or 73 75 1374 1376 O
active 76 82 1377 1383 B-chronic_disease
infection 83 92 1384 1393 I-chronic_disease
and 93 96 1394 1397 O
sepsis 97 103 1398 1404 B-chronic_disease
, 103 104 1404 1405 O
symptomatic 105 116 1406 1417 B-chronic_disease
congestive 117 127 1418 1428 I-chronic_disease
heart 128 133 1429 1434 I-chronic_disease
failure 134 141 1435 1442 I-chronic_disease
, 141 142 1442 1443 O
unstable 143 151 1444 1452 B-chronic_disease
angina 152 158 1453 1459 I-chronic_disease
pectoris 159 167 1460 1468 I-chronic_disease
, 167 168 1468 1469 O
cardiac 169 176 1470 1477 B-chronic_disease
arrhythmia 177 187 1478 1488 I-chronic_disease
, 187 188 1488 1489 O
or 189 191 1490 1492 O
psychiatric 192 203 1493 1504 B-chronic_disease
illness 204 211 1505 1512 I-chronic_disease
/ 211 212 1512 1513 I-chronic_disease
social 212 218 1513 1519 I-chronic_disease

alkaline 0 8 1520 1528 B-clinical_variable
phosphatase 9 20 1529 1540 I-clinical_variable
< 21 22 1541 1542 O
2 23 24 1543 1544 B-upper_bound
ULN 25 28 1545 1548 I-upper_bound

fasting 0 7 1549 1556 B-clinical_variable
glucose 8 15 1557 1564 I-clinical_variable
> 16 17 1565 1566 O
or 18 20 1567 1569 O
equal 21 26 1570 1575 O
to 27 29 1576 1578 O
7.0 30 33 1579 1582 B-lower_bound
mmol 34 38 1583 1587 I-lower_bound
/ 38 39 1587 1588 I-lower_bound
L 39 40 1588 1589 I-lower_bound
( 41 42 1590 1591 I-lower_bound
126 42 45 1591 1594 I-lower_bound
mg 46 48 1595 1597 I-lower_bound
/ 48 49 1597 1598 I-lower_bound
dL 49 51 1598 1600 I-lower_bound
) 51 52 1600 1601 I-lower_bound

lactation 0 9 1602 1611 O
in 10 12 1612 1614 O
women 13 18 1615 1620 B-gender
of 19 21 1621 1623 O
child 22 27 1624 1629 O
bearing 28 35 1630 1637 O
age 36 39 1638 1641 B-age
( 40 41 1642 1643 O
confirmed 41 50 1643 1652 O
by 51 53 1653 1655 O
negative 54 62 1656 1664 B-pregnancy
pregnancy 63 72 1665 1674 I-pregnancy
test 73 77 1675 1679 O
prior 78 83 1680 1685 O
to 84 86 1686 1688 O
start 87 92 1689 1694 O
of 93 95 1695 1697 O
therapy 96 103 1698 1705 B-treatment
) 103 104 1705 1706 O

ny 0 2 1707 1709 O
increase 3 11 1710 1718 O
in 12 14 1719 1721 O
lymphadenopathy 15 30 1722 1737 B-chronic_disease
over 31 35 1738 1742 O
best 36 40 1743 1747 O
response 41 49 1748 1756 O
that 50 54 1757 1761 O
has 55 58 1762 1765 O
persisted 59 68 1766 1775 O
for 69 72 1776 1779 O
more 73 77 1780 1784 O
than 78 82 1785 1789 O
3 83 84 1790 1791 B-lower_bound
months 85 91 1792 1798 I-lower_bound

serum 0 5 1799 1804 B-clinical_variable
conjugated 6 16 1805 1815 I-clinical_variable
bilirubin 17 26 1816 1825 I-clinical_variable
< 27 28 1826 1827 O
1.5 29 32 1828 1831 B-upper_bound
ULN 33 36 1832 1835 I-upper_bound

serum 0 5 1836 1841 B-clinical_variable
creatinine 6 16 1842 1852 I-clinical_variable
less 17 21 1853 1857 O
than 22 26 1858 1862 O
or 27 29 1863 1865 O
equal 30 35 1866 1871 O
to 36 38 1872 1874 O
1.5 39 42 1875 1878 B-upper_bound
in 43 45 1879 1881 O
males 46 51 1882 1887 B-gender
, 51 52 1887 1888 O
or 53 55 1889 1891 O
1.4 56 59 1892 1895 B-upper_bound
in 60 62 1896 1898 O
females 63 70 1899 1906 B-gender

